HRP20031021B1 - Stereoselective method for the preparation of nucleoside analogues - Google Patents

Stereoselective method for the preparation of nucleoside analogues

Info

Publication number: HRP20031021B1
Authority: HR; Croatia
Prior art keywords: formula; bromine; iodine; chlorine; alkoxy
Prior art date: 2001-06-15

Application number

HR20031021A

Other languages

English (en)

Croatian (hr)

Inventor

Yu Qing

Original Assignee

Shire Biochem Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-15

Filing date

2003-12-09

Publication date

2007-09-30

2003-12-09 Application filed by Shire Biochem Inc. filed Critical Shire Biochem Inc.

2004-06-30 Publication of HRP20031021A2 publication Critical patent/HRP20031021A2/xx

2007-09-30 Publication of HRP20031021B1 publication Critical patent/HRP20031021B1/xx

Links

238000000034 method Methods 0.000 title abstract 2
230000000707 stereoselective effect Effects 0.000 title abstract 2
229940127073 nucleoside analogue Drugs 0.000 title 1
239000002777 nucleoside Substances 0.000 abstract 4
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 3
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 3
229910052794 bromium Inorganic materials 0.000 abstract 3
229910052801 chlorine Inorganic materials 0.000 abstract 3
239000000460 chlorine Chemical group 0.000 abstract 3
229910052731 fluorine Inorganic materials 0.000 abstract 3
239000011737 fluorine Substances 0.000 abstract 3
150000003833 nucleoside derivatives Chemical class 0.000 abstract 3
125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 2
125000003860 C1-C20 alkoxy group Chemical group 0.000 abstract 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
230000008878 coupling Effects 0.000 abstract 2
238000010168 coupling process Methods 0.000 abstract 2
238000005859 coupling reaction Methods 0.000 abstract 2
125000001153 fluoro group Chemical group F* 0.000 abstract 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
239000002841 Lewis acid Substances 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
230000003197 catalytic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
239000011630 iodine Substances 0.000 abstract 1
150000007517 lewis acids Chemical class 0.000 abstract 1
125000003835 nucleoside group Chemical class 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
230000000737 periodic effect Effects 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1
150000003512 tertiary amines Chemical class 0.000 abstract 1
125000004665 trialkylsilyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Saccharide Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

HR20031021A 2001-06-15 2003-12-09 Stereoselective method for the preparation of nucleoside analogues HRP20031021B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29807901P	2001-06-15	2001-06-15
PCT/CA2002/000899 WO2002102796A1 (en)	2001-06-15	2002-06-14	Stereoselective method for the preparation of nucleoside analogues

Publications (2)

Publication Number	Publication Date
HRP20031021A2 HRP20031021A2 (en)	2004-06-30
HRP20031021B1 true HRP20031021B1 (en)	2007-09-30

Family

ID=23148927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20031021A HRP20031021B1 (en)	2001-06-15	2003-12-09	Stereoselective method for the preparation of nucleoside analogues

Country Status (29)

Country	Link
US (2)	US7109334B2 (ko)
EP (2)	EP1632490B1 (ko)
JP (1)	JP4542776B2 (ko)
KR (1)	KR100832617B1 (ko)
CN (1)	CN1297553C (ko)
AP (1)	AP1559A (ko)
AT (2)	ATE313542T1 (ko)
AU (2)	AU2002344862C1 (ko)
BR (2)	BRPI0210444B1 (ko)
CA (1)	CA2449338C (ko)
CO (1)	CO5550497A2 (ko)
CY (1)	CY1107805T1 (ko)
DE (2)	DE60208202T2 (ko)
DK (2)	DK1632490T3 (ko)
EA (1)	EA006372B1 (ko)
ES (2)	ES2254695T3 (ko)
HK (1)	HK1070652A1 (ko)
HR (1)	HRP20031021B1 (ko)
IL (2)	IL159139A0 (ko)
MX (1)	MXPA03011627A (ko)
NO (1)	NO326135B1 (ko)
NZ (1)	NZ529906A (ko)
OA (1)	OA12628A (ko)
PL (2)	PL215267B1 (ko)
PT (1)	PT1632490E (ko)
RS (1)	RS50868B (ko)
SI (2)	SI1406896T1 (ko)
WO (1)	WO2002102796A1 (ko)
ZA (1)	ZA200309307B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7501514B1 (en)	2003-10-15	2009-03-10	Shire Biochem, Inc.	Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
JP4653966B2 (ja) *	2004-04-19	2011-03-16	ダイセル化学工業株式会社	２−ベンゾイルオキシアセトアルデヒド誘導体の製造法
IN2015DN02599A (ko) *	2007-09-28	2015-09-18	Avexa Ltd
US20130165350A1 (en) *	2011-12-22	2013-06-27	Affymetrix, Inc.	Surface linkers for array synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR840001591A (ko) *	1981-09-29	1984-05-07	구라바야시 이꾸시로	당케탈류의 제조방법
AU8864191A (en) *	1990-11-13	1992-06-11	Biochem Pharma Inc.	Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US5587480A (en) *	1990-11-13	1996-12-24	Biochem Pharma, Inc.	Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US5532349A (en) *	1993-07-20	1996-07-02	Mitsui Toatsu Chemicals, Inc.	Process for producing 1-(2'-deoxy-β-D-erythro-pentofuranosyl)-5-trifluoromethyluracil derivatives
CA2714085C (en) *	1998-08-12	2013-02-05	Emory University	Method of manufacture of 1,3-oxathiolane nucleosides

2002
- 2002-06-14 AP APAP/P/2003/002948A patent/AP1559A/en active
- 2002-06-14 AU AU2002344862A patent/AU2002344862C1/en not_active Ceased
- 2002-06-14 EP EP05017130A patent/EP1632490B1/en not_active Expired - Lifetime
- 2002-06-14 EA EA200400042A patent/EA006372B1/ru not_active IP Right Cessation
- 2002-06-14 BR BRPI0210444-0A patent/BRPI0210444B1/pt unknown
- 2002-06-14 IL IL15913902A patent/IL159139A0/xx unknown
- 2002-06-14 SI SI200230273T patent/SI1406896T1/sl unknown
- 2002-06-14 DE DE60208202T patent/DE60208202T2/de not_active Expired - Lifetime
- 2002-06-14 NZ NZ529906A patent/NZ529906A/xx not_active IP Right Cessation
- 2002-06-14 CA CA2449338A patent/CA2449338C/en not_active Expired - Fee Related
- 2002-06-14 JP JP2003506269A patent/JP4542776B2/ja not_active Expired - Fee Related
- 2002-06-14 US US10/170,418 patent/US7109334B2/en not_active Expired - Fee Related
- 2002-06-14 ES ES02742572T patent/ES2254695T3/es not_active Expired - Lifetime
- 2002-06-14 CN CNB028159624A patent/CN1297553C/zh not_active Expired - Fee Related
- 2002-06-14 PL PL366907A patent/PL215267B1/pl unknown
- 2002-06-14 SI SI200230631T patent/SI1632490T1/sl unknown
- 2002-06-14 WO PCT/CA2002/000899 patent/WO2002102796A1/en active IP Right Grant
- 2002-06-14 MX MXPA03011627A patent/MXPA03011627A/es active IP Right Grant
- 2002-06-14 KR KR1020037016301A patent/KR100832617B1/ko not_active IP Right Cessation
- 2002-06-14 AT AT02742572T patent/ATE313542T1/de active
- 2002-06-14 DK DK05017130T patent/DK1632490T3/da active
- 2002-06-14 RS YUP-975/03A patent/RS50868B/sr unknown
- 2002-06-14 PT PT05017130T patent/PT1632490E/pt unknown
- 2002-06-14 ES ES05017130T patent/ES2293445T3/es not_active Expired - Lifetime
- 2002-06-14 EP EP02742572A patent/EP1406896B8/en not_active Expired - Lifetime
- 2002-06-14 AT AT05017130T patent/ATE370945T1/de active
- 2002-06-14 DK DK02742572T patent/DK1406896T3/da active
- 2002-06-14 OA OA1200300329A patent/OA12628A/en unknown
- 2002-06-14 DE DE60222031T patent/DE60222031T2/de not_active Expired - Lifetime
- 2002-06-14 BR BR0210444-0A patent/BR0210444A/pt not_active IP Right Cessation
- 2002-06-14 PL PL401835A patent/PL218777B1/pl unknown
2003
- 2003-11-28 ZA ZA2003/09307A patent/ZA200309307B/en unknown
- 2003-12-01 IL IL159139A patent/IL159139A/en not_active IP Right Cessation
- 2003-12-09 HR HR20031021A patent/HRP20031021B1/xx not_active IP Right Cessation
- 2003-12-12 NO NO20035556A patent/NO326135B1/no not_active IP Right Cessation
2004
- 2004-01-14 CO CO04002061A patent/CO5550497A2/es active IP Right Grant
2005
- 2005-04-18 HK HK05103299A patent/HK1070652A1/xx not_active IP Right Cessation
2006
- 2006-04-07 US US11/399,502 patent/US7230100B2/en not_active Expired - Fee Related
2007
- 2007-11-15 CY CY20071101481T patent/CY1107805T1/el unknown
2008
- 2008-08-01 AU AU2008203443A patent/AU2008203443B2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2002102796A1 (en)	2002-12-27
EP1632490A1 (en)	2006-03-08
US7109334B2 (en)	2006-09-19
EA006372B1 (ru)	2005-12-29
RS50868B (sr)	2010-08-31
ATE313542T1 (de)	2006-01-15
ES2293445T3 (es)	2008-03-16
HRP20031021A2 (en)	2004-06-30
JP4542776B2 (ja)	2010-09-15
US7230100B2 (en)	2007-06-12
EP1406896A1 (en)	2004-04-14
CA2449338C (en)	2012-02-07
IL159139A (en)	2010-04-15
PL218777B1 (pl)	2015-01-30
DK1632490T3 (da)	2008-01-28
AU2008203443B2 (en)	2011-06-16
YU97503A (sh)	2006-05-25
AU2002344862C1 (en)	2009-02-19
AU2008203443A1 (en)	2008-08-21
KR20040017233A (ko)	2004-02-26
EP1632490B1 (en)	2007-08-22
ES2254695T3 (es)	2006-06-16
ATE370945T1 (de)	2007-09-15
MXPA03011627A (es)	2005-03-07
CO5550497A2 (es)	2005-08-31
HK1070652A1 (en)	2005-06-24
EP1406896B8 (en)	2006-11-15
KR100832617B1 (ko)	2008-05-27
SI1632490T1 (sl)	2008-02-29
PT1632490E (pt)	2007-11-07
OA12628A (en)	2006-06-13
CA2449338A1 (en)	2002-12-27
NO20035556D0 (no)	2003-12-12
DE60208202T2 (de)	2006-08-17
DE60222031D1 (de)	2007-10-04
ZA200309307B (en)	2005-02-23
JP2004535428A (ja)	2004-11-25
IL159139A0 (en)	2004-06-01
DE60208202D1 (de)	2006-01-26
CY1107805T1 (el)	2013-06-19
PL401835A1 (pl)	2013-02-18
DE60222031T2 (de)	2008-05-21
SI1406896T1 (sl)	2006-04-30
WO2002102796A8 (en)	2003-09-18
BRPI0210444B1 (pt)	2017-06-20
NZ529906A (en)	2006-03-31
NO326135B1 (no)	2008-10-06
CN1297553C (zh)	2007-01-31
US20030135048A1 (en)	2003-07-17
AP1559A (en)	2006-01-24
AU2002344862B2 (en)	2008-05-01
EA200400042A1 (ru)	2004-06-24
EP1406896B1 (en)	2005-12-21
DK1406896T3 (da)	2006-05-08
BR0210444A (pt)	2004-08-17
PL215267B1 (pl)	2013-11-29
PL366907A1 (en)	2005-02-07
CN1543463A (zh)	2004-11-03
US20060183899A1 (en)	2006-08-17

Legal Events

Date	Code	Title	Description
2004-06-30	A1OB	Publication of a patent application
2004-12-10	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
2007-09-30	B1PR	Patent granted
2008-10-21	PNAN	Change of the applicant name, address/residence	Owner name: SHIRE CANADA INC., CA Owner name: SHIRE BIOCHEM INC., CA
2017-05-23	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20170523 Year of fee payment: 16
2018-12-19	PBON	Lapse due to non-payment of renewal fee	Effective date: 20180614

Publication	Publication Date	Title
HUP9904680A2 (hu)	2000-05-28	Tieno-pirimidin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ATE253581T1 (de)	2003-11-15	Verfahren zur herstellung von 3,4- alkylendioxythiophen-2,5-dicarbonsäurederivaten
DE60307179D1 (de)	2006-09-14	Vor UV-Strahlen schützende Zusammensetzungen
RS20050380A (en)	2007-11-15	3-amino piperidine derivatives and methods of manufacture
HUP0201385A2 (hu)	2003-12-29	Eljárás a 4"-szubsztituált 9-dezoxo-9a-aza-9a-homoeritromicin-A-származékok előállítására
CO4920234A1 (es)	2000-05-29	Derivados de acidos arilsulfonilaminomidroxamicos
IL101932A (en)	1997-04-15	Processes for the diastereoselective synthesis of cis-nucleoside analogues
WO2003080580A3 (en)	2004-02-05	Quinoline derivatives and their use as 5-ht6 ligands
RS50919B (sr)	2010-08-31	Derivati merkaptoacetilamida, postupak za njihovo pripremanje i njihova upotreba
HUP0300909A2 (hu)	2003-10-28	NHE-3 inhibitor hatású 2-guanidino-4-aril-kinazolin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0300052A2 (en)	2003-05-28	Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists, process for their preparation and pharmaceutical compositions containing them
ATE331713T1 (de)	2006-07-15	Verfahren zur herstellung von 5-nitrobenzofuranen
HUP0401684A2 (hu)	2004-12-28	Heterociklusos nikotinsav-amidok és analóg pirimidinszármazékok mint kártevőírtók
NO20051126L (no)	2005-03-02	Fremgangsmate for fremstilling av kinolon-antibiotikumintermediater
ES8203845A1 (es)	1982-04-01	Procedimiento para preparar derivados de piridoxina
TW200503993A (en)	2005-02-01	Arylalkylcarbamate derivatives, their preparation and their application in therapy
HRP20031021B1 (en)	2007-09-30	Stereoselective method for the preparation of nucleoside analogues
PE20040520A1 (es)	2004-08-24	Derivados de n-acilamino bencil eter
EP1295878A4 (en)	2004-01-28	NEW PYRAZINONE DERIVATIVES
HUP0000572A2 (hu)	2001-05-28	Nukleotid analógot tartalmazó gyógyszerkészítmények és eljárás előállításukra
AR037211A1 (es)	2004-10-27	Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1
HUP0203364A2 (hu)	2003-02-28	Eljárás 3-helyettesített-4-arilkinolin-2-on származékok előállítására
US20020035256A1 (en)	2002-03-21	Novel synthesis of piperazine ring
ATE256108T1 (de)	2003-12-15	Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
EA200101209A1 (ru)	2002-06-27	Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их